FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 165 of 165

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
SXTP Nasdaq 60 Degrees Pharmaceuticals, Inc. 2834
TARS Nasdaq Tarsus Pharmaceuticals, Inc. 2834
TELO Nasdaq Telomir Pharmaceuticals, Inc. 2834
TEVA New York Teva Pharmaceutical Industries Limited 2834
TLPH Nasdaq Talphera, Inc. 2834
TLSA Nasdaq Tiziana Life Sciences Ltd 2834
TRDA Nasdaq Entrada Therapeutics, Inc. 2834
TRVI Nasdaq Trevi Therapeutics, Inc. 2834
UCBJY Over the counter UCB SA 2834
VBIO Nasdaq Valion Bio, Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2834
VTRS Nasdaq Viatris Inc. 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
XLO Nasdaq Xilio Therapeutics, Inc. 2834
ZURA Nasdaq Zura Bio Limited 2834
Results 150 through 165 of 165